| Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007 T Morgenthaler, C Alessi, L Friedman, J Owens, V Kapur, B Boehlecke, ... Sleep 30 (4), 519-529, 2007 | 1433 | 2007 |
| Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders CA Kushida, MR Littner, M Hirshkowitz, TI Morgenthaler, CA Alessi, ... Sleep 29 (3), 375-380, 2006 | 1041 | 2006 |
| Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders TI Morgenthaler, T Lee-Chiong, C Alessi, L Friedman, RN Aurora, ... Sleep 30 (11), 1445-1459, 2007 | 766 | 2007 |
| Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin TI Morgenthaler, VK Kapur, TM Brown, TJ Swick, C Alessi, RN Aurora, ... Sleep 30 (12), 1705-1711, 2007 | 550 | 2007 |
| Practice parameters for the use of autotitrating continuous positive airway pressure devices for titrating pressures and treating adult patients with obstructive sleep apnea … TI Morgenthaler, RN Aurora, T Brown, R Zak, C Alessi, B Boehlecke, ... Sleep 31 (1), 141-147, 2008 | 463 | 2008 |
| Disrupted nighttime sleep in narcolepsy T Roth, Y Dauvilliers, E Mignot, J Montplaisir, J Paul, T Swick, P Zee Journal of Clinical Sleep Medicine 9 (9), 955-965, 2013 | 213 | 2013 |
| Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic study WG Ondo, T Perkins, T Swick, KL Hull, JE Jimenez, TS Garris, D Pardi Archives of neurology 65 (10), 1337-1340, 2008 | 169 | 2008 |
| Sodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in fibromyalgia: results from a 14-week, randomized, double-blind, placebo-controlled study IJ Russell, AJ Holman, TJ Swick, S Alvarez-Horine, YG Wang, D Guinta, ... Pain 152 (5), 1007-1017, 2011 | 125 | 2011 |
| Safety overview of postmarketing and clinical experience of sodium oxybate (Xyrem): abuse, misuse, dependence, and diversion YG Wang, TJ Swick, LP Carter, MJ Thorpy, NL Benowitz Journal of clinical sleep medicine 5 (4), 365-371, 2009 | 112 | 2009 |
| Effect of oral JZP-110 (ADX-N05) on wakefulness and sleepiness in adults with narcolepsy: a phase 2b study C Ruoff, TJ Swick, R Doekel, HA Emsellem, NT Feldman, R Rosenberg, ... Sleep 39 (7), 1379-1387, 2016 | 81 | 2016 |
| Parkinson′ s Disease and Sleep/Wake Disturbances TJ Swick Parkinson’s Disease 2012 (1), 205471, 2012 | 63 | 2012 |
| The neurology of sleep TJ Swick Neurologic clinics 23 (4), 967-989, 2005 | 59 | 2005 |
| Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment K Maski, LM Trotti, S Kotagal, R Robert Auger, TJ Swick, JA Rowley, ... Journal of Clinical Sleep Medicine 17 (9), 1895-1945, 2021 | 58 | 2021 |
| Amer ican academy of sleep medicine. Practice parameters for the psychological and behavioral treatment of insomnia: an update. An american academy of sleep medicine report T Morgenthaler, M Kramer, C Alessi, L Friedman, B Boehlecke, T Brown, ... Sleep 29 (11), 1415, 2006 | 55 | 2006 |
| Treatment paradigms for cataplexy in narcolepsy: past, present, and future TJ Swick Nature and science of sleep, 159-169, 2015 | 53 | 2015 |
| Evaluation of quality of life in patients with narcolepsy treated with sodium oxybate: use of the 36-item short-form health survey in a clinical trial R Bogan, T Swick, M Mamelak, R Kovacevic-Ristanovic, C Lai, J Black, ... Neurology and therapy 5, 203-213, 2016 | 32 | 2016 |
| Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy J Black, T Swick, R Bogan, C Lai, LP Carter Sleep medicine 24, 57-62, 2016 | 27 | 2016 |
| A 12-week open-label, multicenter study evaluating the safety and patient-reported efficacy of sodium oxybate in patients with narcolepsy and cataplexy M Mamelak, T Swick, H Emsellem, J Montplaisir, C Lai, J Black Sleep medicine 16 (1), 52-58, 2015 | 27 | 2015 |
| Oral orexin receptor 2 agonist in narcolepsy type 1 Y Dauvilliers, E Mignot, R del Río Villegas, Y Du, E Hanson, Y Inoue, ... New England Journal of Medicine 389 (4), 309-321, 2023 | 25 | 2023 |
| Associations between severity of motor function and nonmotor symptoms in Parkinson's disease: a post hoc analysis of the RECOVER Study TJ Swick, JH Friedman, KR Chaudhuri, E Surmann, B Boroojerdi, ... European Neurology 71 (3-4), 140-147, 2014 | 23 | 2014 |
